|
遠大醫藥集團有限公司, 00512.HK - 綜合損益表 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
營業額 |
10,529,590 |
9,562,285 |
8,597,975 |
6,352,919 |
6,590,635 |
5,958,355 |
4,770,850 |
3,696,164 |
3,245,546 |
3,122,116 |
2,658,282 |
2,059,307 |
1,647,576 |
1,054,754 |
545,435 |
269,882 |
49,045 |
42,408 |
46,384 |
經營溢利 |
2,408,341 |
2,597,121 |
2,671,970 |
2,011,604 |
1,241,011 |
814,720 |
560,730 |
316,914 |
246,236 |
202,352 |
131,979 |
115,520 |
98,960 |
133,386 |
26,359 |
-16,714 |
-55,945 |
-12,524 |
-106,210 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21,631 |
17,244 |
-7,732 |
0 |
0 |
0 |
聯營公司 |
-25,008 |
-43,786 |
113,862 |
61,979 |
114,962 |
69,179 |
-1,791 |
-2,950 |
-5,673 |
569 |
301 |
15 |
504 |
3,149 |
5,183 |
1,759 |
660 |
338 |
-2,594 |
除稅前經營溢利 |
2,344,197 |
2,516,893 |
2,785,832 |
2,073,583 |
1,355,973 |
883,899 |
558,939 |
313,964 |
240,563 |
202,921 |
132,280 |
115,535 |
99,464 |
158,166 |
48,786 |
-22,687 |
-55,285 |
-12,186 |
-108,804 |
稅項 |
448,755 |
418,642 |
380,800 |
292,374 |
230,485 |
147,460 |
73,181 |
44,602 |
40,156 |
27,198 |
26,994 |
10,830 |
12,793 |
3,889 |
6,873 |
-4 |
-2,205 |
-245 |
0 |
少數股東權益 |
15,444 |
18,832 |
2,469 |
-11,452 |
-25,460 |
23,772 |
24,947 |
219 |
19,501 |
515 |
5,628 |
37,400 |
32,436 |
56,304 |
13,569 |
3,516 |
-1,855 |
-1,291 |
-11,590 |
股東應占溢利 |
1,879,998 |
2,079,419 |
2,402,563 |
1,792,661 |
1,150,948 |
712,667 |
460,811 |
269,143 |
180,906 |
175,208 |
99,658 |
67,305 |
54,235 |
97,973 |
28,344 |
-24,233 |
-52,030 |
-10,650 |
-97,214 |
貨幣 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
392,210 |
394,912 |
339,519 |
287,061 |
477,136 |
236,315 |
243,263 |
219,428 |
191,378 |
171,234 |
96,871 |
69,251 |
52,737 |
29,429 |
11,282 |
9,831 |
8,554 |
5,327 |
8,619 |
利息 |
205,145 |
137,493 |
92,964 |
115,421 |
146,502 |
203,296 |
174,427 |
181,678 |
157,155 |
114,092 |
77,633 |
41,801 |
26,405 |
51,960 |
26,847 |
16,064 |
9,228 |
5,746 |
3,925 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
19.14 |
16.63 |
13.67 |
14.1 |
17.0 |
16.68 |
13.09 |
14.21 |
16.69 |
13.4 |
20.41 |
9.37 |
12.86 |
2.46 |
14.09 |
|
|
|
|
營業額增長(%) |
10.12 |
11.22 |
35.34 |
-3.61 |
10.61 |
24.89 |
29.08 |
13.88 |
3.95 |
17.45 |
29.09 |
24.99 |
56.2 |
93.38 |
102.1 |
450.27 |
15.65 |
-8.57 |
-26.56 |
股東應占溢利增長(%) |
-9.59 |
-13.45 |
34.02 |
55.76 |
61.5 |
54.65 |
71.21 |
48.78 |
3.25 |
75.81 |
48.07 |
24.1 |
-44.64 |
245.66 |
|
|
|
|
|
核數師意見 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|